Analytical comparability demonstrated for an IgG4 molecule, inclacumab, following transfer of manufacturing responsibility from Roche to Global Blood Therapeutics

.

Source: Expert Opinion on Biological Therapy - November 9, 2022 Category: Drugs & Pharmacology Authors: Radu Mihaila Dipali Ruhela Lifang Xu Sandra Joussef Xin Geng Jianxia Shi Andrea S. Kim Wendy Yares Kevin Furstoss Kent Iverson Source Type: research